| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/26/2009 | CA2304801C Transcriptionally-activated aav inverted terminal repeats (itrs) for use with recombinant aav vectors |
| 05/26/2009 | CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/26/2009 | CA2295322C Methods and compositions for rapid purification of proteasomes and methods of use of components thereof |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/26/2009 | CA2091102C Microsomal triglyceride transfer protein |
| 05/22/2009 | WO2009065143A2 Hydroxypolyamide gel forming agents |
| 05/22/2009 | WO2009065123A1 Hydrogel networks having living cells encapsulated therein |
| 05/22/2009 | WO2009065093A2 Use of stem cells for wound healing |
| 05/22/2009 | WO2009065091A1 Method of efficient extraction of protein from cells |
| 05/22/2009 | WO2009065080A1 Compositions and method for manipulating pim-1 activity in circulatory system cells |
| 05/22/2009 | WO2009065001A2 Cardiac conduction system (ccs) progenitor cells and uses thereof |
| 05/22/2009 | WO2009064958A1 Ex-vivo production of human demineralized bone matrix |
| 05/22/2009 | WO2009064924A1 Compositions and methods for making androstenediones |
| 05/22/2009 | WO2009064922A1 Production of bone morphogenic proteins (bmps) using a novel tissue culture platform |
| 05/22/2009 | WO2009064917A2 Generation of an hla-negative osteogenic precursor cell line |
| 05/22/2009 | WO2009064448A1 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/22/2009 | WO2009063965A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 05/22/2009 | WO2009063722A1 Mammalian artificial chromosome vector carrying human cytochrome p450 gene (cluster), and non-human mammal harboring the vector |
| 05/22/2009 | WO2009063312A2 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism |
| 05/22/2009 | WO2009062789A1 Improving the secretory capacity in host cells |
| 05/22/2009 | WO2009062512A1 Method for generating tolerogenic dendritic cells employing decreased temperature |
| 05/22/2009 | WO2009062502A1 Method for generating tolerogenic dendritic cells employing decreased temperature |
| 05/22/2009 | WO2009062470A1 Use of nanopatterned surfaces and method for enriching or isolating cellular subpopulations |
| 05/22/2009 | WO2009062313A1 Composition containing granulocyte colony stimulating factor (gcsf) for hair growth |
| 05/22/2009 | WO2009062309A1 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 05/22/2009 | WO2009062259A1 Genetically modified plants with altered inflorescence |
| 05/22/2009 | WO2009062253A1 Genetically modified chrysanthemums |
| 05/22/2009 | WO2009045819A3 Symbiotic biological systems as platforms for sensing, production, and intervention |
| 05/22/2009 | WO2009044379A3 Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord |
| 05/22/2009 | WO2009042186A3 Genomic editing in zebrafish using zinc finger nucleases |
| 05/22/2009 | WO2009035612A3 Multilineage-inducible cells and uses thereof |
| 05/22/2009 | WO2008140573A3 Methods for reversibly binding a biotin compound to a support |
| 05/22/2009 | WO2008125989A3 Polyketide based proteasome inhibitor |
| 05/22/2009 | WO2008034133A3 Effect of tula on hiv |
| 05/22/2009 | WO2007139970A3 Men1 gene for diagnosis and treatment of diabetes |
| 05/22/2009 | WO2007026353A3 Media for culturing stem cells |
| 05/22/2009 | WO2006120667A3 Expression constructs and methods of using same for expressing heparanase in plants |
| 05/22/2009 | WO2006088867A3 Method for expansion of stem cells |
| 05/22/2009 | WO2006072954A3 Novel il-6 polynucleotides encoding variant il-6 polypeptides and methods using same |
| 05/22/2009 | CA2706549A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 05/22/2009 | CA2705923A1 Antibodies to lrp6 |
| 05/22/2009 | CA2705862A1 Compositions and method for manipulating pim-1 activity in circulatory system cells |
| 05/22/2009 | CA2705841A1 Mammalian artificial chromosome vector comprising human cytochrome p450 gene (cluster) and non-human mammalian animal retaining the same |
| 05/22/2009 | CA2705758A1 Cold storage of organotypically cultured skin equivalents for clinical applications |
| 05/22/2009 | CA2705376A1 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 05/22/2009 | CA2688306A1 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism |
| 05/21/2009 | US20090133164 EG1117 polynucleotides and uses thereof |
| 05/21/2009 | US20090133163 Promoter, promoter control elements, and combinations, and uses thereof |
| 05/21/2009 | US20090133161 ethylene sensitivity is decreased; transgenic plants; agronomics |
| 05/21/2009 | US20090133160 Polyoleosins |
| 05/21/2009 | US20090133159 Soybean ef1a2 promoter and its use in constitutive expression of transgenic genes in plants |
| 05/21/2009 | US20090133158 Bs3 resistance gene and methods of use |
| 05/21/2009 | US20090133156 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics and phenotypes |
| 05/21/2009 | US20090133155 Modification of Flavonoid Biosynthesis in Plants |
| 05/21/2009 | US20090133151 Flower Pigmentation in Pelargonium hortorum |
| 05/21/2009 | US20090133150 Cotton variety 04z353 |
| 05/21/2009 | US20090133149 Cotton variety 04z007 |
| 05/21/2009 | US20090133148 Cotton variety 02z89 |
| 05/21/2009 | US20090133144 Cotton variety 04t067 |
| 05/21/2009 | US20090133143 Cotton variety 04t056 |
| 05/21/2009 | US20090133139 Nucleotide sequence of shrimp actin promoter and its use in genetic transformation biotechnology |
| 05/21/2009 | US20090133137 Method of cloning animals |
| 05/21/2009 | US20090133136 Inducible SIRNA expression cassette and method of use |
| 05/21/2009 | US20090133135 Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases |
| 05/21/2009 | US20090133134 Method and composition for genetically modifying non-human cells and animals |
| 05/21/2009 | US20090131637 Vanilloid receptor |
| 05/21/2009 | US20090131634 Method for Preparing Cell Fraction Containing Hemangioblasts |
| 05/21/2009 | US20090131524 Sialic acid abc transporters in prokaryotes therapeutic targets |
| 05/21/2009 | US20090131485 Deuterated pirfenidone |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131357 Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG15 and/or UBP43 |
| 05/21/2009 | US20090131355 Multicistronic vectors and methods for their design |
| 05/21/2009 | US20090131354 miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 05/21/2009 | US20090131351 Methods, compositions, and kits for modulating tumor cell proliferation |
| 05/21/2009 | US20090131350 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 05/21/2009 | US20090131327 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same |
| 05/21/2009 | US20090131320 Peptides modulating the activity of the engrailed transcription factor |
| 05/21/2009 | US20090131319 Protein of given amino acid sequence; heterologous polypeptide comprises Fc portion of antibody molecule; identifying agonists and antagonists; diagnosis and treatment of disease resulting from aberrant cell proliferation |
| 05/21/2009 | US20090131318 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 05/21/2009 | US20090131312 Non-natural chemokine receptor ligands and methods of use thereof |
| 05/21/2009 | US20090131310 Mucin3 egf-like domains |
| 05/21/2009 | US20090131309 Ica512 couples insulin secretion and gene expression in beta-cells |
| 05/21/2009 | US20090131308 Splice Variants of ErbB Ligands, Compositions and Uses Thereof |
| 05/21/2009 | US20090131259 Hydroxypolyamide Gel Forming Agents |
| 05/21/2009 | US20090130762 Activation of HCV-specific T cells |
| 05/21/2009 | US20090130759 Culture Medium Containing Kinase Inhibitor, and Use Thereof |
| 05/21/2009 | US20090130758 insecticidal activity of the protein against Lepidopteran pests (moths); biological pesticides |
| 05/21/2009 | US20090130757 Bioreactor with mixer and sparger |
| 05/21/2009 | US20090130756 Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles |
| 05/21/2009 | US20090130755 Hydrogel networks having living cells encapsulated therein |
| 05/21/2009 | US20090130754 Method for culturing human embryonic stem cells |
| 05/21/2009 | US20090130753 Method for Obtaining and Storing Multipotent Stem Cells |
| 05/21/2009 | US20090130716 Rationally designed antibodies |
| 05/21/2009 | US20090130715 Antibodies to CD40 |
| 05/21/2009 | US20090130712 Compositions and Methods of Producing Hybrid Antigen Binding Molecules and Uses Thereof |
| 05/21/2009 | US20090130710 Enhancing vegetative protein production in transgenic plants using seed specific promoters |
| 05/21/2009 | US20090130709 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 05/21/2009 | US20090130701 Novel sequence variants of multi-drug resistance genes, mdr1 and mrp1, and recombinant cells expressing mrp1 and mdr1 for assessment of drug penetration and disposition |
| 05/21/2009 | US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 05/21/2009 | US20090130692 Use of microproteins as tryptase |